These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11227728)

  • 1. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.
    Clerico A; Caprioli R; Del Ry S; Giannessi D
    J Endocrinol Invest; 2001 Jan; 24(1):24-30. PubMed ID: 11227728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
    Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B
    Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
    Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
    Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides in patients with aortic stenosis.
    Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
    Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
    Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C; Metzele A; Steffgen J; Grünert A
    Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.
    Hammerer-Lercher A; Neubauer E; Müller S; Pachinger O; Puschendorf B; Mair J
    Clin Chim Acta; 2001 Aug; 310(2):193-7. PubMed ID: 11498085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
    Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
    Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].
    Bertinchant JP
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
    Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
    Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Boomsma F; van Veldhuisen DJ
    Eur J Heart Fail; 2005 Jan; 7(1):81-6. PubMed ID: 15642536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
    Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
    Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers.
    Hammerer-Lercher A; Ludwig W; Falkensammer G; Müller S; Neubauer E; Puschendorf B; Pachinger O; Mair J
    Clin Chem; 2004 Jul; 50(7):1174-83. PubMed ID: 15142976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
    Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.
    Nakagawa Y; Nishikimi T; Kuwahara K; Yasuno S; Kinoshita H; Kuwabara Y; Nakao K; Minami T; Yamada C; Ueshima K; Ikeda Y; Okamoto H; Horii K; Nagata K; Kangawa K; Minamino N; Nakao K
    PLoS One; 2014; 9(3):e92314. PubMed ID: 24667631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis.
    Goto T; Takase H; Toriyama T; Sugiura T; Kurita Y; Tsuru N; Masuda H; Hayashi K; Ueda R; Dohi Y
    Nephron; 2002; 92(3):610-5. PubMed ID: 12372945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
    Ala-Kopsala M; Magga J; Peuhkurinen K; Leipälä J; Ruskoaho H; Leppäluoto J; Vuolteenaho O
    Clin Chem; 2004 Sep; 50(9):1576-88. PubMed ID: 15265819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.